StonvexLoading…
StonvexStonvexStonvexCore line items from DMRC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $33.91M | $38.42M | $34.85M | $30.20M |
Operating Income | $-33.16M | $-41.31M | $-48.21M | $-61.81M |
Net Income | $-32.31M | $-39.01M | $-45.96M | $-59.80M |
EPS (Diluted) | $-1.49 | $-1.83 | $-2.26 | $-3.12 |
Total Assets | $52.96M | $75.77M | $80.55M | $113.78M |
Total Liabilities | $12.73M | $14.41M | $18.63M | $16.19M |
Cash & Equivalents | $9.82M | $12.37M | $21.46M | $33.60M |
Free Cash Flow OCF − CapEx | $-12.35M | $-26.78M | $-22.31M | $-45.34M |
Shares Outstanding | 21.90M | 21.50M | 20.38M | 20.26M |